Sarcopenia is not associated with poor outcomes after transjugular intrahepatic portosystemic shunt insertion for refractory ascites
Thomas H. Tranah(King's College - North Carolina), Debbie L. Shawcross(King's College - North Carolina), Swathi Rajagopal, Zillah Cargill, Oliver Tavabie, Sarah Brown(University of Leeds), Pauline Kane, Brian Hogan
Cited by 1
Related Papers
Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial
|The Lancet|2010|640
Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial
|The Lancet|2015|477
Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial
|The Lancet Oncology|2013|392
Clinical development of new drug–radiotherapy combinations
|Nature Reviews Clinical Oncology|2016|317